Shay Capital LLC acquired a new position in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 5,700 shares of the company's stock, valued at approximately $547,000.
A number of other institutional investors have also recently bought and sold shares of the business. Barclays PLC lifted its holdings in shares of HealthEquity by 209.3% during the 3rd quarter. Barclays PLC now owns 166,492 shares of the company's stock valued at $13,628,000 after buying an additional 112,667 shares during the last quarter. Assenagon Asset Management S.A. acquired a new stake in shares of HealthEquity during the 4th quarter valued at about $1,452,000. Hennion & Walsh Asset Management Inc. acquired a new stake in shares of HealthEquity during the 4th quarter valued at about $215,000. Avanza Fonder AB acquired a new stake in shares of HealthEquity during the 4th quarter valued at about $381,000. Finally, HB Wealth Management LLC acquired a new stake in shares of HealthEquity during the 4th quarter valued at about $261,000. 99.55% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity
In related news, Director Robert W. Selander sold 5,750 shares of the company's stock in a transaction dated Wednesday, April 9th. The stock was sold at an average price of $77.65, for a total value of $446,487.50. Following the completion of the sale, the director now owns 84,969 shares in the company, valued at approximately $6,597,842.85. This represents a 6.34% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, EVP Michael Henry Fiore sold 8,881 shares of the company's stock in a transaction dated Friday, April 4th. The shares were sold at an average price of $78.26, for a total value of $695,027.06. Following the completion of the sale, the executive vice president now owns 56,655 shares of the company's stock, valued at $4,433,820.30. This represents a 13.55% decrease in their position. The disclosure for this sale can be found here. 2.20% of the stock is currently owned by insiders.
Analyst Upgrades and Downgrades
HQY has been the subject of several research reports. The Goldman Sachs Group reduced their price target on HealthEquity from $107.00 to $94.00 and set a "neutral" rating for the company in a report on Thursday, March 27th. KeyCorp reduced their target price on HealthEquity from $110.00 to $100.00 and set an "overweight" rating for the company in a report on Wednesday, April 16th. Wells Fargo & Company boosted their target price on HealthEquity from $110.00 to $125.00 and gave the stock an "overweight" rating in a report on Wednesday, February 26th. Raymond James raised HealthEquity from an "outperform" rating to a "strong-buy" rating and dropped their price target for the stock from $120.00 to $115.00 in a research report on Tuesday, March 25th. Finally, Barrington Research reaffirmed an "outperform" rating and issued a $112.00 price target on shares of HealthEquity in a research report on Friday, April 11th. One analyst has rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Buy" and an average target price of $111.75.
Check Out Our Latest Report on HealthEquity
HealthEquity Price Performance
HealthEquity stock traded up $3.58 on Tuesday, reaching $101.18. The company's stock had a trading volume of 1,142,791 shares, compared to its average volume of 798,121. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. The company has a market cap of $8.75 billion, a price-to-earnings ratio of 92.83, a PEG ratio of 1.60 and a beta of 0.45. The business's fifty day moving average price is $87.92 and its 200 day moving average price is $97.20. HealthEquity, Inc. has a twelve month low of $65.01 and a twelve month high of $115.59.
About HealthEquity
(
Free Report)
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Featured Articles
Before you consider HealthEquity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthEquity wasn't on the list.
While HealthEquity currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
